P450 biotechnology

Cytochrome P450: Structure, Mechanism, and Biochemistry, Fourth Edition

Volumn , Issue , 2015, Pages 451-520

  Girhard, Marco ^a   Bakkes, Patrick J ^a   Mahmoud, Osama ^a   Urlacher, Vlada B ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84945117807     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-319-12108-6_8     Document Type: Chapter

References (442)

1. Chen MS, White MC (2007) A predictably selective aliphatic C-H oxidation reaction for complex molecule synthesis Science 318:783-787
2. Godula K, Sames D (2006) C-H bond functionalization in complex organic synthesis Science 312:67-72
3. Newhouse T, Baran PS (2011) If C-H bonds could talk: selective C-H bond oxidation Angew Chem Int Ed Engl 50:3362-3374
4. Fasan R (2012) Tuning P450 enzymes as oxidation catalysts ACS Catal 2:647-666
5. Lewis JC, Coelho PS, Arnold FH (2011) Enzymatic functionalization of carbon-hydrogen bonds Chem Soc Rev 40:2003-2021
6. Garfinkel D (1958) Studies on pig liver microsomes. I. Enzymic and pigment composition of different microsomal fractions Arch Biochem Biophys 77:493-509
7. Klingenberg M (1958) Pigments of rat liver microsomes Arch Biochem Biophys 75:376-386
8. Davies HG, Green RH, Kelly DR, Roberts SM (1989) Biotransformations in preparative organic chemistry: the use of isolated enzymes and whole-cell systems in synthesis Academic, London, pp 1-23
9. Bernhardt R (1996) Cytochrome P450: structure, function, and generation of reactive oxygen species Rev Physiol Biochem Pharmacol 127:137-221
10. Hlavica P, Kunzel-Mulas U (1993) Metabolic N-oxide formation by rabbit-liver microsomal cytochrome P-4502B4: involvement of superoxide in the NADPH-dependent N-oxygenation of N, N-dimethylaniline Biochim Biophys Acta 1158:83-90
11. Seto Y, Guengerich FP (1993) Partitioning between N-dealkylation and N-oxygenation in the oxidation of N, N-dialkylarylamines catalyzed by cytochrome P450 2B1 J Biol Chem 268:9986-9997
12. Kashiyama E, Yokoi T, Odomi M, Funae Y, Inoue K, Kamataki T (1997) Cytochrome P450 responsible for the stereoselective S-oxidation of flosequinan in hepatic microsomes from rats and humans Drug Metab Dispos 25:716-724
13. Bischoff D, Bister B, Bertazzo M, Pfeifer V, Stegmann E, Nicholson GJ, Keller S, Pelzer S, Wohlleben W, Sussmuth RD (2005) The biosynthesis of vancomycin-type glycopeptide antibiotics-a model for oxidative side-chain cross-linking by oxygenases coupled to the action of peptide synthetases Chembiochem 6:267-272
14. Dalvie DK, O'Connell TN (2004) Characterization of novel dihydrothienopyridinium and thienopyridinium metabolites of ticlopidine in vitro: role of peroxidases, cytochromes P450, and monoamine oxidases Drug Metab Dispos 32:49-57
15. Kim TW, Hwang JY, Kim YS, Joo SH, Chang SC, Lee JS, Takatsuto S, Kim SK (2005) Arabidopsis CYP85A2, a cytochrome P450, mediates the Baeyer- Villiger oxidation of castasterone to brassinolide in brassinosteroid biosynthesis Plant Cell 17:2397- 2412
16. Cryle MJ, Stok JE, De Voss JJ (2003) Reactions catalyzed by bacterial cytochromes P450 Aust J Chem 56:749-762
17. Isin EM, Guengerich FP (2007) Complex reactions catalyzed by cytochrome P450 enzymes Biochim Biophys Acta 1770:314-329
18. Ortiz de Montellano PR, Nelson SD (2011) Rearrangement reactions catalyzed by cytochrome P450s Arch Biochem Biophys 507:95-110
19. Bernhardt R (2006) Cytochromes P450 as versatile biocatalysts J Biotechnol 124:128-145
20. Guengerich FP (2001) Uncommon P450-catalyzed reactions Curr Drug Metab 2:93-115
21. Urlacher VB, Eiben S (2006) Cytochrome P450 monooxygenases: perspectives for synthetic application Trends Biotechnol 24:324-330
22. Sono M, Roach MP, Coulter ED, Dawson JH (1996) Heme-containing oxygenases Chem Rev 96:2841- 2888
23. Guengerich FP, Munro AW (2013) Unusual cytochrome P450 enzymes and reactions J Biol Chem 288:17065-17073
24. Barry SM, Kers JA, Johnson EG, Song L, Aston PR, Patel B, Krasnoff SB, Crane BR, Gibson DM, Loria R, Challis GL (2012) Cytochrome P450-catalyzed L-tryptophan nitration in thaxtomin phytotoxin biosynthesis Nat Chem Biol 8:814-816
25. Coelho PS, Brustad EM, Kannan A, Arnold FH (2013) Olefin cyclopropanation via carbene transfer catalyzed by engineered cytochrome P450 enzymes Science 339:307-310
26. McIntosh JA, Coelho PS, Farwell CC, Wang ZJ, Lewis JC, Brown TR, Arnold FH (2013) Enantioselective intramolecular C-H amination catalyzed by engineered cytochrome P450 enzymes in vitro and in vivo Angew Chem Int Ed Engl 52:9309-9312
27. Schuler MA, Werck-Reichhart D (2003) Functional genomics of P450s Annu Rev Plant Biol 54:629-667
28. Trager WF (1989) Stereochemistry of cytochrome P450 reactions Drug Metab Rev 20:489-496
29. Gonzalez FJ, Korzekwa KR (1995) Cytochromes P450 expression systems Annu Rev Pharmacol Toxicol 35:369-390
30. Park JB (2007) Oxygenase-based whole-cell biocatalysis in organic synthesis J Microbiol Biotechnol 17:379-392
31. Pawlowska M, Augustin E (2011) Expression systems of cytochrome P450 proteins in studies of drug metabolism in vitro Postepy Hig Med Dosw (Online) 65:367-376
32. Yabusaki Y (1998) Expression of mammalian cytochromes P450 in yeast Methods Mol Biol 107:195- 202
33. Zelasko S, Palaria A, Das A (2013) Optimizations to achieve high-level expression of cytochrome P450 proteins using Escherichia coli expression systems Protein Expr Purif 20:00143-00145
34. van Beilen JB, Duetz WA, Schmid A, Witholt B (2003) Practical issues in the application of oxygenases Trends Biotechnol 21:170-177
35. Hannemann F, Bichet A, Ewen KM, Bernhardt R (2007) Cytochrome P450 systems-biological variations of electron transport chains Biochim Biophys Acta 1770:330-344
36. Ewen KM, Hannemann F, Iametti S, Morleo A, Bernhardt R (2011) Functional characterization of Fdx1: evidence for an evolutionary relationship between P450-type and ISC-type ferredoxins J Mol Biol 413:940-951
37. Ewen KM, Kleser M, Bernhardt R (2010) Adrenodoxin: the archetype of vertebrate-type [2Fe-2S] cluster ferredoxins Biochim Biophys Acta 1814:111-125
38. Hanukoglu I, Rapoport R, Weiner L, Sklan D (1993) Electron leakage from the mitochondrial NADPHadrenodoxin reductase-adrenodoxin-P450scc (cholesterol side chain cleavage) system Arch Biochem Biophys 305:489-498
39. Sligar SG, Makris TM, Denisov IG (2005) Thirty years of microbial P450 monooxygenase research: peroxo-heme intermediates-the central bus station in heme oxygenase catalysis Biochem Biophys Res Commun 338:346-354
40. Loida PJ, Sligar SG (1993) Molecular recognition in cytochrome P450-mechanism for the control of uncoupling reactions Biochemistry 32:11530-11538
41. Makris TM, Davydov R, Denisov IG, Hoffman BM, Sligar SG (2002) Mechanistic enzymology of oxygen activation by the cytochromes P450 Drug Metab Rev 34:691-708
42. Nelson DR (2013) A world of cytochrome P450s Philos Trans R Soc Lond B Biol Sci 368:20120430
43. Furuya T, Kino K (2010) Genome mining approach for the discovery of novel cytochrome P450 biocatalysts Appl Microbiol Biotechnol 86:991-1002
44. Thaker MN, Wang W, Spanogiannopoulos P, Waglechner N, King AM, Medina R, Wright GD (2013) Identifying producers of antibacterial compounds by screening for antibiotic resistance Nat Biotechnol 31:922-927
45. D'Onofrio A, Crawford JM, Stewart EJ, Witt K, Gavrish E, Epstein S, Clardy J, Lewis K (2010) Siderophores from neighboring organisms promote the growth of uncultured bacteria Chem Biol 17:254- 264
46. Schmeisser C, Steele H, Streit WR (2007) Metagenomics, biotechnology with non-culturable microbes Appl Microbiol Biotechnol 75:955-962
47. Nelson DR (1999) Cytochrome P450 and the individuality of species Arch Biochem Biophys 369:1-10
48. Nelson DR (2006) Cytochrome P450 nomenclature, Methods Mol Biol 320:1-10
49. Nelson DR (2010) Progress in tracing the evolutionary paths of cytochrome P450 Biochim Biophys Acta 1814:14-18
50. Nelson DR (2009) The cytochrome P450 homepage Hum Genomics 4:59-65
51. Fischer M, Knoll M, Sirim D, Wagner F, Funke S, Pleiss J (2007) The cytochrome P450 engineering database: a navigation and prediction tool for the cytochrome P450 protein family Bioinformatics 23:2015-2017
52. Sirim D, Wagner F, Lisitsa A, Pleiss J (2009) The cytochrome P450 engineering database: integration of biochemical properties BMC Biochem 10:27
53. Park J, Lee S, Choi J, Ahn K, Park B, Kang S, Lee YH (2008) Fungal cytochrome P450 database BMC Genomics 9:402
54. Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R (2010) SuperCYP: a comprehensive database on cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions Nucleic Acids Res 38:D237-243
55. Schulz S, Girhard M, Urlacher VB (2012) Biocatalysis: key to selective oxidations Chem Cat Chem 4:1889-1895
56. Liese A, Zelinski T, Kula MR, Kierkels H, Karutz M, Kragl U, Wandrey C (1998) A novel reactor concept for the enzymatic reduction of poorly soluble ketones J Mol Catal B Enzym 4:91-99
57. Kim KR, Oh DK (2013) Production of hydroxy fatty acids by microbial fatty acid-hydroxylation enzymes Biotechnol Adv 31:1473-1485
58. Funhoff EG, van Beilen JB (2007) Alkane activation by P450 oxygenases Biocatal Biotransform 25:186- 193
59. van Beilen JB, Funhoff EG, van Loon A, Just A, Kaysser L, Bouza M, Holtackers R, Rothlisberger M, Li Z, Witholt B (2006) Cytochrome P450 alkane hydroxylases of the CYP153 family are common in alkane-degrading eubacteria lacking integral membrane alkane hydroxylases Appl Environ Microbiol 72:59-65
60. Kubota M, Nodate M, Yasumoto-Hirose M, Uchiyama T, Kagami O, Shizuri Y, Misawa N (2005) Isolation and functional analysis of cytochrome P450 CYP153A genes from various environments Biosci Biotechnol Biochem 69:2421-2430
61. Funhoff EG, Salzmann J, Bauer U, Witholt B, van Beilen JB (2007) Hydroxylation and epoxidation reactions catalyzed by CYP153 enzymes Enzyme Microb Technol 40:806-812
62. Gudiminchi RK, Randall C, Opperman DJ, Olaofe OA, Harrison STL, Albertyn J, Smit MS (2012) Whole-cell hydroxylation of n-octane by Escherichia coli strains expressing the CYP153A6 operon Appl Microbiol Biotechnol 96:1507-1516
63. Scheps D, Malca SH, Hoffmann H, Nestl BM, Hauer B (2011) Regioselective ω-hydroxylation of mediumchain n-alkanes and primary alcohols by CYP153 enzymes from Mycobacterium marinum and Polaromonas sp strain JS666 Org Biomol Chem 9:6727- 6733
64. Honda Malca S, Scheps D, Kühnel L, Venegas-Venegas E, Seifert A, Nestl BM, Hauer B (2012) Bacterial CYP153A monooxygenases for the synthesis of omega-hydroxylated fatty acids Chem Commun (Camb) 48:5115-5117
65. von Buhler CJ, Urlacher VB (2014) A novel P450- based biocatalyst for the selective production of chiral 2-alkanols Chem Commun (Camb) 50:4089-4091
66. Craft DL, Madduri KM, Eshoo M, Wilson CR (2003) Identification and characterization of the CYP52 family of Candida tropicalis ATCC 20336, important for the conversion of fatty acids and alkanes to alpha, omega-dicarboxylic acids Appl Environ Microbiol 69:5983-5991
67. Ohkuma M, Muraoka S, Tanimoto T, Fujii M, Ohta A, Takagi M (1995) CYP52 (cytochrome P450alk) multigene family in Candida maltosa: identification and characterization of eight members DNA Cell Biol 14:163-173
68. Takai H, Iwama R, Kobayashi S, Horiuchi H, Fukuda R, Ohta A (2012) Construction and characterization of a Yarrowia lipolytica mutant lacking genes encoding cytochromes P450 subfamily 52 Fungal Genet Biol 49:58-64
69. Kim D, Cryle MJ, Voss JJ, Ortiz de Montellano PR (2007) Functional expression and characterization of cytochrome P450 52A21 from Candida albicans Arch Biochem Biophys 464:213-220
70. van Bogaert IN, De Mey M, Develter D, Soetaert W, Vandamme EJ (2009) Importance of the cytochrome P450 monooxygenase CYP52 family for the sophorolipid- producing yeast Candida bombicola FEMS Yeast Res 9:87-94
71. Zhao Y-J, Cheng Q-Q, Su P, Chen X, Wang X-J, Gao W, Huang L-Q (2014) Research progress relating to the role of cytochrome P450 in the biosynthesis of terpenoids in medicinal plants Appl Microbiol Biotechnol 98:2371-2383
72. Hardwick JP (2008) Cytochrome P450 omega hydroxylase (CYP4) function in fatty acid metabolism and metabolic diseases Biochem Pharmacol 75:2263-2275
73. Edson KZ, Rettie AE (2013) CYP4 Enzymes as potential drug targets: focus on enzyme multiplicity, inducers and inhibitors, and therapeutic modulation of 20-hydroxyeicosatetraenoic acid (20-HETE) synthase and fatty acid omega-hydroxylase activities Curr Top Med Chem 13:1429-1440
74. Gandhi AV, Saxena S, Relles D, Sarosiek K, Kang CY, Chipitsyna G, Sendecki JA, Yeo CJ, Arafat HA (2013) Differential expression of cytochrome P450 omega-hydroxylase isoforms and their association with clinicopathological features in pancreatic ductal adenocarcinoma Ann Surg Oncol 20:S636-S643
75. Nakano M, Kelly EJ, Rettie AE (2009) Expression and characterization of CYP4V2 as a fatty acid omegahydroxylase Drug Metab Dispos 37:2119-2122
76. Fisher MB, Zheng YM, Rettie AE (1998) Positional specificity of rabbit CYP4B1 for omega-hydroxylation of short-medium chain fatty acids and hydrocarbons Biochem Biophys Res Commun 248:352-355
77. Cane DE, Ikeda H (2012) Exploration and mining of the bacterial terpenome Acc Chem Res 45:463-472
78. Schewe H, Mirata MA, Holtmann D, Schrader J (2011) Biooxidation of monoterpenes with bacterial monooxygenases Process Biochem 46:1885-1899
79. Serra S, Fuganti C, Brenna E (2005) Biocatalytic preparation of natural flavours and fragrances. Trends Biotechnol 23:193-198
80. Ro DK, Paradise EM, Ouellet M, Fisher KJ, Newman KL, Ndungu JM, Ho KA, Eachus RA, Ham TS, Kirby J, Chang MC, Withers ST, Shiba Y, Sarpong R, Keasling JD (2006) Production of the antimalarial drug precursor artemisinic acid in engineered yeast Nature 440:940-943
81. Chang MC, Eachus RA, Trieu W, Ro DK, Keasling JD (2007) Engineering Escherichia coli for production of functionalized terpenoids using plant P450s Nat Chem Biol 3:274-277
82. Eschenmoser W, Uebelhart P, Eugster CH (1981) Synthesis and chirality of the enantiomeric 6-hydroxy-alpha-ionones and of cis and trans-5,6-dihydroxy- 5,6-dihydro-beta-ionones Helv Chim Acta 64:2681-2690
83. Roberts DL, Heckman RA, Hege BP, Bellin SA (1968) Synthesis of (RS)-abscisic acid J Org Chem 33:3566-3569
84. Dietrich M, Eiben S, Asta C, Do TA, Pleiss J, Urlacher VB (2008) Cloning, expression and characterisation of CYP102A7, a self-sufficient P450 monooxygenase from Bacillus licheniformis Appl Microbiol Biotechnol 79:931-940
85. Girhard M, Klaus T, Khatri Y, Bernhardt R, Urlacher VB (2010) Characterization of the versatile monooxygenase CYP109B1 from Bacillus subtilis Appl Microbiol Biotechnol 87:595-607
86. Khatri Y, Girhard M, Romankiewicz A, Ringle M, Hannemann F, Urlacher VB, Hutter MC, Bernhardt R (2010) Regioselective hydroxylation of norisoprenoids by CYP109D1 from Sorangium cellulosum So ce56 Appl Microbiol Biotechnol 88:485-495
87. Ly TTB, Khatri Y, Zapp J, Hutter MC, Bernhardt R (2012) CYP264B1 from Sorangium cellulosum So ce56: a fascinating norisoprenoid and sesquiterpene hydroxylase Appl Microbiol Biotechnol 95:123-133
88. Bleif S, Hannemann F, Lisurek M, Kries JP, Zapp J, Dietzen M, Antes I, Bernhardt R (2011) Identification of CYP106A2 as a regioselective allylic bacterial diterpene hydroxylase Chembiochem 12:576-582
89. Bleif S, Hannemann F, Zapp J, Hartmann D, Jauch J, Bernhardt R (2012) A new Bacillus megaterium whole-cell catalyst for the hydroxylation of the pentacyclic triterpene 11-keto-beta-boswellic acid (KBA) based on a recombinant cytochrome P450 system Appl Microbiol Biotechnol 93:1135-1146
90. Schmitz D, Zapp J, Bernhardt R (2012) Hydroxylation of the triterpenoid dipterocarpol with CYP106A2 from Bacillus megaterium FEBS J 279:1663-1674
91. Janocha S, Zapp J, Hutter M, Kleser M, Bohlmann J, Bernhardt R (2013) Resin acid conversion with CYP105A1: an enzyme with potential for the production of pharmaceutically relevant diterpenoids Chembiochem 14:467-473
92. Janocha S, Bernhardt R (2013) Design and characterization of an efficient CYP105A1-based whole-cell biocatalyst for the conversion of resin acid diterpenoids in permeabilized Escherichia coli Appl Microbiol Biotechnol 97:7639-7649
93. Zhan J (2009) Biosynthesis of bacterial aromatic polyketides Curr Top Med Chem 9:1958-1610
94. Gomez-Escribano JP, Bibb MJ (2014) Heterologous expression of natural product biosynthetic gene clusters in Streptomyces coelicolor: from genome mining to manipulation of biosynthetic pathways J Ind Microbiol Biotechnol 41:425-431
95. Guengerich FP, Tang Z, Salamanca-Pinzon SG, Cheng Q (2010) Characterizing proteins of unknown function: orphan cytochrome P450 enzymes as a paradigm Mol Interv 10:153-163
96. Lamb DC, Waterman MR, Zhao B (2013) Streptomyces cytochromes P450: applications in drug metabolism Expert Opin Drug Metab Toxicol 9:1279- 1294
97. Sherman DH, Li S, Yermalitskaya LV, Kim Y, Smith JA, Waterman MR, Podust LM (2006) The structural basis for substrate anchoring, active site selectivity, and product formation by P450 PikC from Streptomyces venezuelae J Biol Chem 281:26289-26297
98. Lee SK, Park JW, Kim JW, Jung WS, Park SR, Choi CY, Kim ES, Kim BS, Ahn JS, Sherman DH, Yoon YJ (2006) Neopikromycin and novapikromycin from the pikromycin biosynthetic pathway of Streptomyces venezuelae J Nat Prod 69:847-849
99. Lee SK, Basnet DB, Hong JSJ, Jung WS, Choi CY, Lee HC, Sohng JK, Ryu KG, Kim DJ, Ahn JS, Kim BS, Oh HC, Sherman DH, Yoon YJ (2005) Structural diversification of macrolactones by substrateflexible cytochrome P450 monooxygenases Adv Synth Catal 347:1369-1378
100. Basnet DB, Park JW, Yoon YJ (2008) Combinatorial biosynthesis of 5-O-desosaminyl erythronolide A as a potent precursor of ketolide antibiotics J Biotechnol 135:92-96
101. Anzai Y, Li S, Chaulagain MR, Kinoshita K, Kato F, Montgomery J, Sherman DH (2008) Functional analysis of MycCI and MycG, cytochrome P450 enzymes involved in biosynthesis of mycinamicin macrolide antibiotics Chem Biol 15:950-959
102. Urlacher VB, Girhard M (2012) Cytochrome P450 monooxygenases: an update on perspectives for synthetic application Trends Biotechnol 30:26-36
103. Lamb DC, Guengerich FP, Kelly SL, Waterman MR (2006) Exploiting Streptomyces coelicolor A3(2) P450s as a model for application in drug discovery Expert Opin Drug Metab Toxicol 2:27-40
104. Gillam EM (2008) Engineering cytochrome P450 enzymes Chem Res Toxicol 21:220-231
105. Grogan G (2011) Cytochromes P450: exploiting diversity and enabling application as biocatalysts Curr Opin Chem Biol 15:241-248
106. Jung ST, Lauchli R, Arnold FH (2011) Cytochrome P450: taming a wild type enzyme Curr Opin Biotechnol 22:809-817
107. McIntosh JA, Farwell CC, Arnold FH (2014) Expanding P450 catalytic reaction space through evolution and engineering Curr Opin Chem Biol 19C:126-134
108. O'Reilly E, Kohler V, Flitsch SL, Turner NJ (2011) Cytochromes P450 as useful biocatalysts: addressing the limitations Chem Commun (Camb) 47:2490-2501
109. Whitehouse CJ, Bell SG, Wong LL (2012) P450(BM3) (CYP102A1): connecting the dots Chem Soc Rev 41:1218-1260
110. Bornscheuer UT, Pohl M (2001) Improved biocatalysts by directed evolution and rational protein design Curr Opin Chem Biol 5:137-143
111. Arnold FH (2009) How proteins adapt: lessons from directed evolution Cold Spring Harb Symp Quant Biol 74:41-46
112. McLean KJ, Girvan HM, Munro AW (2007) Cytochrome P450/redox partner fusion enzymes: biotechnological and toxicological prospects Expert Opin Drug Metab Toxicol 3:847-863
113. Capdevila JH, Wei S, Helvig C, Falck JR, Belosludtsev Y, Truan G, Graham-Lorence SE, Peterson JA (1996) The highly stereoselective oxidation of polyunsaturated fatty acids by cytochrome P450 BM-3 J Biol Chem 271:22663-22671
114. Narhi LO, Fulco AJ (1986) Characterization of a catalytically self-sufficient 119,000-dalton cytochrome P-450 monooxygenase induced by barbiturates in Bacillus megaterium J Biol Chem 261:7160-7169
115. Fasan R, Chen MM, Crook NC, Arnold FH (2007) Engineered alkane-hydroxylating cytochrome P450 BM3 exhibiting nativelike catalytic properties Angew Chem Int Ed Engl 46:8414-8418
116. Appel D, Lutz-Wahl S, Fischer P, Schwaneberg U, Schmid RD (2001) A P450 BM-3 mutant hydroxylates alkanes, cycloalkanes, arenes and heteroarenes J Biotechnol 88:167-171
117. Budde M, Morr M, Schmid RD, Urlacher VB (2006) Selective hydroxylation of highly branched fatty acids and their derivatives by CYP102A1 from Bacillus megaterium Chembiochem 7:789-794
118. Li QS, Ogawa J, Schmid RD, Shimizu S (2001) Engineering cytochrome P450 BM3 for oxidation of polycyclic aromatic hydrocarbons Appl Environ Microbiol 67:5735-5739
119. Li QS, Schwaneberg U, Fischer P, Schmid RD (2000) Directed evolution of the fatty-acid hydroxylase P450 BM3 into an indole-hydroxylating catalyst Chemistry 6:1531-1536
120. Sulistyaningdyah WT, Ogawa J, Li QS, Shinkyo R, Sakaki T, Inouye K, Schmid RD, Shimizu S (2004) Metabolism of polychlorinated dibenzo-p-dioxins by cytochrome P450 BM3 and its mutant Biotechnol Lett 26:1857-1860
121. Watanabe Y, Laschat S, Budde M, Affolter O, Shimada Y, Urlacher VB (2007) Oxidation of acyclic monoterpenes by P450 BM3 monooxygenase: influence of the substrate E/Z-isomerism on enzyme chemo- and regioselectivity Tetrahedron 63 9413-9422
122. van Vugt-Lussenburg BM, Damsten MC, Maasdijk DM, Vermeulen NP, Commandeur JN (2006) Heterotropic and homotropic cooperativity by a drugmetabolising mutant of cytochrome P450 BM3 Biochem Biophys Res Commun 346:810-818
123. Otey CR, Bandara G, Lalonde J, Takahashi K, Arnold FH (2006) Preparation of human metabolites of propranolol using laboratory-evolved bacterial cytochromes P450 Biotechnol Bioeng 93:494-499
124. Landwehr M, Hochrein L, Otey CR, Kasrayan A, Backvall JE, Arnold FH (2006) Enantioselective alpha-hydroxylation of 2-arylacetic acid derivatives and buspirone catalyzed by engineered cytochrome P450 BM3 J Am Chem Soc 128:6058-6059
125. Damsten MC, van Vugt-Lussenburg BM, Zeldenthuis T, de Vlieger JS, Commandeur JN, Vermeulen NP (2008) Application of drug metabolising mutants of cytochrome P450 BM3 (CYP102A1) as biocatalysts for the generation of reactive metabolites Chem Biol Interact 171:96-107
126. Damsten MC, de Vlieger JS, Niessen WM, Irth H, Vermeulen NP, Commandeur JN (2008) Trimethoprim: novel reactive intermediates and bioactivation pathways by cytochrome P450s Chem Res Toxicol 21:2181-2187
127. Kadkhodayan S, Coulter ED, Maryniak DM, Bryson TA, Dawson JH (1995) Uncoupling oxygen transfer and electron transfer in the oxygenation of camphor analogues by cytochrome P450cam Direct observation of an intermolecular isotope effect for substrate C-H activation J Biol Chem 270:28042-28048
128. Bell SG, Stevenson JA, Boyd HD, Campbell S, Riddle AD, Orton EL, Wong LL (2002) Butane and propane oxidation by engineered cytochrome P450cam Chem Commun (Camb) 5:490-491
129. Xu F, Bell SG, Lednik J, Insley A, Rao Z, Wong LL (2005) The heme monooxygenase cytochrome P450cam can be engineered to oxidize ethane to ethanol Angew Chem Int Ed Engl 44:4029-4032
130. Huang W, Johnston WA, Hayes MA, De Voss JJ, Gillam EM (2007) A shuffled CYP2C library with a high degree of structural integrity and functional versatility Arch Biochem Biophys 467:193-205
131. Robinson JK, Pollack SV, Robins P (1980) Invasion of cartilage by basal cell carcinoma J Am Acad Dermatol 2:499-505
132. Pikuleva IA, Bjorkhem I, Waterman MR (1996) Studies of distant members of the P450 superfamily (P450scc and P450c27) by random chimeragenesis Arch Biochem Biophys 334:183-192
133. Chen CK, Berry RE, Shokhireva T, Murataliev MB, Zhang H, Walker FA (2010) Scanning chimeragenesis: the approach used to change the substrate selectivity of fatty acid monooxygenase CYP102A1 to that of terpene omega-hydroxylase CYP4C7 J Biol Inorg Chem 15:159-174
134. Chen CK, Shokhireva T, Berry RE, Zhang H, Walker FA (2008) The effect of mutation of F87 on the properties of CYP102A1-CYP4C7 chimeras: altered regiospecificity and substrate selectivity J Biol Inorg Chem 13:813-824
135. Otey CR, Landwehr M, Endelman JB, Hiraga K, Bloom JD, Arnold FH (2006) Structure-guided recombination creates an artificial family of cytochromes P450 PLoS Biol 4:e112
136. Li Y, Drummond DA, Sawayama AM, Snow CD, Bloom JD, Arnold FH (2007) A diverse family of thermostable cytochrome P450s created by recombination of stabilizing fragments Nat Biotechnol 25:1051-1056
137. Kang JY, Ryu SH, Park SH, Cha GS, Kim DH, Kim KH, Hong AW, Ahn T, Pan JG, Joung YH, Kang HS, Yun CH (2014) Chimeric cytochromes P450 engineered by domain swapping and random mutagenesis for producing human metabolites of drugs Biotechnol Bioeng 111:1313-1322 doi:10 1002/bit 25202
138. Lisurek M, Simgen B, Antes I, Bernhardt R (2008) Theoretical and experimental evaluation of a CYP106A2 low homology model and production of mutants with changed activity and selectivity of hydroxylation Chembiochem 9:1439-1449
139. Nguyen KT, Virus C, Gunnewich N, Hannemann F, Bernhardt R (2012) Changing the regioselectivity of a P450 from C15 to C11 hydroxylation of progesterone Chembiochem 13:1161-1166
140. Seifert A, Pleiss J (2009) Identification of selectivity- determining residues in cytochrome P450 monooxygenases: a systematic analysis of the substrate recognition site 5 Proteins 74:1028-1035
141. Seifert A, Vomund S, Grohmann K, Kriening S, Urlacher VB, Laschat S, Pleiss J (2009) Rational design of a minimal and highly enriched CYP102A1 mutant library with improved regio-, stereo- and chemoselectivity Chembiochem 10:853-861
142. Weber E, Seifert A, Antonovici M, Geinitz C, Pleiss J, Urlacher VB (2011) Screening of a minimal enriched P450 BM3 mutant library for hydroxylation of cyclic and acyclic alkanes Chem Commun (Camb) 47:944-946
143. Kille S, Zilly FE, Acevedo JP, Reetz MT (2011) Regio- and stereoselectivity of P450-catalysed hydroxylation of steroids controlled by laboratory evolution Nat Chem 3:738-743
144. Shoji O, Fujishiro T, Nakajima H, Kim M, Nagano S, Shiro Y, Watanabe Y (2007) Hydrogen peroxide dependent monooxygenations by tricking the substrate recognition of cytochrome P450BSbeta Angew Chem Int Ed Engl 46:3656-3659
145. Shoji O, Fujishiro T, Nagano S, Tanaka S, Hirose T, Shiro Y, Watanabe Y (2010) Understanding substrate misrecognition of hydrogen peroxide dependent cytochrome P450 from Bacillus subtilis J Biol Inorg Chem 15:1331-1339
146. Kawakami N, Shoji O, Watanabe Y (2011) Use of perfluorocarboxylic acids to trick cytochrome P450 BM3 into initiating the hydroxylation of gaseous alkanes Angew Chem Int Ed Engl 50:5315-5318
147. Zilly FE, Acevedo JP, Augustyniak W, Deege A, Hausig UW, Reetz MT (2011) Tuning a P450 enzyme for methane oxidation Angew Chem Int Ed Engl 50:2720-2724
148. Sadeghi SJ, Gilardi G (2013) Chimeric P450 enzymes: activity of artificial redox fusions driven by different reductases for biotechnological applications Biotechnol Appl Biochem 60:102-110
149. Gilardi G, Meharenna YT, Tsotsou GE, Sadeghi SJ, Fairhead M, Giannini S (2002) Molecular Lego: design of molecular assemblies of P450 enzymes for nanobiotechnology Biosens Bioelectron 17:133- 145
150. Sadeghi SJ, Meharenna YT, Fantuzzi A, Valetti F, Gilardi G (2000) Engineering artificial redox chains by molecular 'Lego' Faraday Discuss 116:135-153
151. Sabbadin F, Grogan G, Bruce NC (2013) LICRED: a versatile drop-in vector for rapid generation of redox- self-sufficient cytochromes P450 Methods Mol Biol 987:239-249
152. Sabbadin F, Hyde R, Robin A, Hilgarth EM, Delenne M, Flitsch S, Turner N, Grogan G, Bruce NC (2010) LICRED: a versatile drop-in vector for rapid generation of redox-self-sufficient cytochrome P450s Chembiochem 11:987-994
153. Hirakawa H, Nagamune T (2010) Molecular assembly of P450 with ferredoxin and ferredoxin reductase by fusion to PCNA Chembiochem 11:1517-1520
154. Haga T, Hirakawa H, Nagamune T (2013) Fine tuning of spatial arrangement of enzymes in a PCNAmediated multienzyme complex using a rigid poly- L-proline linker PLoS One 8:e75114
155. Fairhead M, Giannini S, Gillam EM, Gilardi G (2005) Functional characterisation of an engineered multidomain human P450 2E1 by molecular Lego J Biol Inorg Chem 10:842-853
156. Munro AW, Girvan HM, Mason AE, Dunford AJ, McLean KJ (2013) What makes a P450 tick? Trends Biochem Sci 38:140-150
157. Lewis DF, Watson E, Lake BG (1998) Evolution of the cytochrome P450 superfamily: sequence alignments and pharmacogenetics Mutat Res 410:245- 270
158. Munro AW, Girvan HM, McLean KJ (2007) Variations on a (t)heme-novel mechanisms, redox partners and catalytic functions in the cytochrome P450 superfamily Nat Prod Rep 24:585-609
159. Wang LH, Kulmacz RJ (2002) Thromboxane synthase: structure and function of protein and gene Prostaglandins Other Lipid Mediat 68-69:409-422
160. Grechkin AN (2002) Hydroperoxide lyase and divinyl ether synthase Prostaglandins Other Lipid Mediat 68-69:457-470
161. Tijet N, Brash AR (2002) Allene oxide synthases and allene oxides Prostaglandins Other Lipid Mediat 68-69:423-431
162. McLean KJ, Sabri M, Marshall KR, Lawson RJ, Lewis DG, Clift D, Balding PR, Dunford AJ, Warman AJ, McVey JP, Quinn AM, Sutcliffe MJ, Scrutton NS, Munro AW (2005) Biodiversity of cytochrome P450 redox systems Biochem Soc Trans 33:796-801
163. Peterson JA, Lorence MC, Amarneh B (1990) Putidaredoxin reductase and putidaredoxin Cloning, sequence determination, heterologous expression of the proteins J Biol Chem 265:6066-6073
164. Lambeth JD, Stevens VL (1984) Cytochrome P- 450scc: enzymology, and the regulation of intramitochondrial cholesterol delivery to the enzyme Endocr Res 10:283-309
165. Serizawa N, Matsuoka T (1991) A two componenttype cytochrome P450 monooxygenase system in a prokaryote that catalyzes hydroxylation of ML- 236B to pravastatin, a tissue-selective inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase Biochim Biophys Acta 1084:35-40
166. Schenkman JB, Jansson I (2003) The many roles of cytochrome b5 Pharmacol Ther 97:139-152
167. Hawkes DB, Adams GW, Burlingame AL, Ortiz de Montellano PR, De Voss JJ (2002) Cytochrome P450(cin) (CYP176A), isolation, expression, and characterization J Biol Chem 277:27725-27732
168. Meharenna YT, Li H, Hawkes DB, Pearson AG, De Voss J, Poulos TL (2004) Crystal structure of P450cin in a complex with its substrate, 1,8-cineole, a close structural homologue to D-camphor, the substrate for P450cam Biochemistry 43:9487-9494
169. Wright RL, Harris K, Solow B, White RH, Kennelly PJ (1996) Cloning of a potential cytochrome P450 from the archaeon Sulfolobus solfataricus FEBS Lett 384:235-239
170. Jackson CJ, Lamb DC, Marczylo TH, Warrilow AG, Manning NJ, Lowe DJ, Kelly DE, Kelly SL (2002) A novel sterol 14alpha-demethylase/ferredoxin fusion protein (MCCYP51FX) from Methylococcus capsulatus represents a new class of the cytochrome P450 superfamily J Biol Chem 277:46959-46965
171. Rylott EL, Jackson RG, Edwards J, Womack GL, Seth-Smith HM, Rathbone DA, Strand SE, Bruce NC (2006) An explosive-degrading cytochrome P450 activity and its targeted application for the phytoremediation of RDX Nat Biotechnol 24:216- 219
172. De Mot R, Parret AH (2002) A novel class of selfsufficient cytochrome P450 monooxygenases in prokaryotes Trends Microbiol 10:502-508
173. Roberts GA, Celik A, Hunter DJ, Ost TW, White JH, Chapman SK, Turner NJ, Flitsch SL (2003) A selfsufficient cytochrome P450 with a primary structural organization that includes a flavin domain and a [2Fe-2S] redox center J Biol Chem 278:48914- 48920
174. Warman AJ, Roitel O, Neeli R, Girvan HM, Seward HE, Murray SA, McLean KJ, Joyce MG, Toogood H, Holt RA, Leys D, Scrutton NS, Munro AW (2005) Flavocytochrome P450 BM3: an update on structure and mechanism of a biotechnologically important enzyme Biochem Soc Trans 33:747-753
175. Ruettinger RT, Wen LP, Fulco AJ (1989) Coding nucleotide, 5ʹ regulatory, and deduced amino acid sequences of P450 BM3, a single peptide cytochrome P450:NADPH-P450 reductase from Bacillus megaterium J Biol Chem 264:10987-10995
176. Narhi LO, Fulco AJ (1987) Identification and characterization of two functional domains in cytochrome P-450BM-3, a catalytically self-sufficient monooxygenase induced by barbiturates in Bacillus megaterium J Biol Chem 262:6683-6690
177. Miles JS, Munro AW, Rospendowski BN, Smith WE, McKnight J, Thomson AJ (1992) Domains of the catalytically self-sufficient cytochrome P450 BM3 Genetic construction, overexpression, purification and spectroscopic characterization Biochem J 288:503-509
178. Nakayama N, Takemae A, Shoun H (1996) Cytochrome P450foxy, a catalytically self-sufficient fatty acid hydroxylase of the fungus Fusarium oxysporum J Biochem 119:435-440
179. Kitazume T, Takaya N, Nakayama N, Shoun H (2000) Fusarium oxysporum fatty-acid subterminal hydroxylase (CYP505) is a membrane-bound eukaryotic counterpart of Bacillus megaterium cytochrome P450BM3 J Biol Chem 275:39734-39740
180. Daiber A, Shoun H, Ullrich V (2005) Nitric oxide reductase (P450nor) from Fusarium oxysporum J Inorg Biochem 99:185-193
181. Munro AW, Girvan HM, McLean KJ (2007) Cytochrome P450-redox partner fusion enzymes Biochim Biophys Acta 1770:345-359
182. Hlavica P, Lehnerer M (2010) Oxidative biotransformation of fatty acids by cytochromes P450: predicted key structural elements orchestrating substrate specificity, regioselectivity and catalytic efficiency Curr Drug Metab 11:85-104
183. Roberts GA, Grogan G, Greter A, Flitsch SL, Turner NJ (2002) Identification of a new class of cytochrome P450 from a Rhodococcus sp J Bacteriol 184:3898-3908
184. George RA, Heringa J (2002) An analysis of protein domain linkers: their classification and role in protein folding Protein Eng 15:871-879
185. Chen X, Zaro JL, Shen WC (2013) Fusion protein linkers: property, design and functionality Adv Drug Deliv Rev 65:1357-1369
186. Argos P (1990) An investigation of oligopeptides linking domains in protein tertiary structures and possible candidates for general gene fusion J Mol Biol 211:943-958
187. Bai Y, Shen WC (2006) Improving the oral efficacy of recombinant granulocyte colony-stimulating factor and transferrin fusion protein by spacer optimization Pharm Res 23:2116-2121
188. Bergeron LM, Gomez L, Whitehead TA, Clark DS (2009) Self-renaturing enzymes: design of an enzyme-chaperone chimera as a new approach to enzyme stabilization Biotechnol Bioeng 102:1316- 1322
189. Huston JS, Levinson D, Mudgett-Hunter M, Tai MS, Novotny J, Margolies MN, Ridge RJ, Bruccoleri RE, Haber E, Crea R et al (1988) Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli Proc Natl Acad Sci U S A 85:5879-5883
190. Zhao HL, Yao XQ, Xue C, Wang Y, Xiong XH, Liu ZM (2008) Increasing the homogeneity, stability and activity of human serum albumin and interferon- alpha2b fusion protein by linker engineering Protein Expr Purif 61:73-77
191. Arai R, Ueda H, Kitayama A, Kamiya N, Nagamune T (2001) Design of the linkers which effectively separate domains of a bifunctional fusion protein Protein Eng 14:529-532
192. Marqusee S, Baldwin RL (1987) Helix stabilization by Glu-…Lys + salt bridges in short peptides of de novo design Proc Natl Acad Sci U S A 84:8898- 8902
193. McCormick AL, Thomas MS, Heath AW (2001) Immunization with an interferon-gamma-gp120 fusion protein induces enhanced immune responses to human immunodeficiency virus gp120 J Infect Dis 184:1423-1430
194. Goyal A, Batra JK (2000) Inclusion of a furin-sensitive spacer enhances the cytotoxicity of ribotoxin restrictocin containing recombinant single-chain immunotoxins Biochem J 345(Pt 2):247-254
195. Vessillier S, Adams G, Chernajovsky Y (2004) Latent cytokines: development of novel cleavage sites and kinetic analysis of their differential sensitivity to MMP-1 and MMP-3 Protein Eng Des Sel 17:829- 835
196. Hlavica P (2009) Assembly of non-natural electron transfer conduits in the cytochrome P450 system: a critical assessment and update of artificial redox constructs amenable to exploitation in biotechnological areas Biotechnol Adv 27:103-121
197. Murakami H, Yabusaki Y, Sakaki T, Shibata M, Ohkawa H (1987) A genetically engineered P450 monooxygenase: construction of the functional fused enzyme between rat cytochrome P450c and NADPH-cytochrome P450 reductase DNA 6:189- 197
198. Shibata M, Sakaki T, Yabusaki Y, Murakami H, Ohkawa H (1990) Genetically engineered P450 monooxygenases: construction of bovine P450c17/yeast reductase fused enzymes DNA Cell Biol 9:27-36
199. Sakaki T, Shibata M, Yabusaki Y, Murakami H, Ohkawa H (1990) Expression of bovine cytochrome P450c21 and its fused enzymes with yeast NADPHcytochrome P450 reductase in Saccharomyces cerevisiae DNA Cell Biol 9:603-614
200. Shet MS, Fisher CW, Arlotto MP, Shackleton CH, Holmans PL, Martin-Wixtrom CA, Saeki Y, Estabrook RW (1994) Purification and enzymatic properties of a recombinant fusion protein expressed in Escherichia coli containing the domains of bovine P450 17A and rat NADPH-P450 reductase Arch Biochem Biophys 311:402-417
201. Schroder G, Unterbusch E, Kaltenbach M, Schmidt J, Strack D, De Luca V, Schroder J (1999) Lightinduced cytochrome P450-dependent enzyme in indole alkaloid biosynthesis: tabersonine 16-hydroxylase FEBS Lett 458:97-102
202. Lamb DC, Kelly DE, Hanley SZ, Mehmood Z, Kelly SL (1998) Glyphosate is an inhibitor of plant cytochrome P450: functional expression of Thlaspi arvensae cytochrome P45071B1/reductase fusion protein in Escherichia coli Biochem Biophys Res Commun 244:110-114
203. Lamb SB, Lamb DC, Kelly SL, Stuckey DC (1998) Cytochrome P450 immobilisation as a route to bioremediation/biocatalysis FEBS Lett 431:343-346
204. Didierjean L, Gondet L, Perkins R, Lau SM, Schaller H, O'Keefe DP, Werck-Reichhart D (2002) Engineering herbicide metabolism in tobacco and Arabidopsis with CYP76B1, a cytochrome P450 enzyme from Jerusalem artichoke Plant Physiol 130:179-189
205. Sibbesen O, De Voss JJ, Montellano PR (1996) Putidaredoxin reductase-putidaredoxin-cytochrome P450cam triple fusion protein Construction of a self-sufficient Escherichia coli catalytic system J Biol Chem 271:22462-22469
206. Nodate M, Kubota M, Misawa N (2005) Functional expression system for cytochrome P450 genes using the reductase domain of self-sufficient P450RhF from Rhodococcus sp NCIMB 9784 Appl Microbiol Biotechnol 71:455-462
207. Robin A, Roberts GA, Kisch J, Sabbadin F, Grogan G, Bruce N, Turner NJ, Flitsch SL (2009) Engineering and improvement of the efficiency of a chimeric [P450cam-RhFRed reductase domain] enzyme Chem Commun (Camb) 14:2478-2480
208. Dodhia VR, Fantuzzi A, Gilardi G (2006) Engineering human cytochrome P450 enzymes into catalytically self-sufficient chimeras using molecular Lego J Biol Inorg Chem 11:903-916
209. Fuziwara S, Sagami I, Rozhkova E, Craig D, Noble MA, Munro AW, Chapman SK, Shimizu T (2002) Catalytically functional flavocytochrome chimeras of P450 BM3 and nitric oxide synthase J Inorg Biochem 91:515-526
210. Schuckel J, Rylott EL, Grogan G, Bruce NC (2012) A gene-fusion approach to enabling plant cytochromes P450 for biocatalysis Chembiochem 13:2758-2763
211. Peterson JA, Boddupalli SS (1992) P450 BM3: reduction by NADPH and sodium dithionite Arch Biochem Biophys 294:654-661
212. Fang X, Halpert JR (1996) Dithionite-supported hydroxylation of palmitic acid by cytochrome P450 BM-3 Drug Metab Dispos 24:1282-1285
213. Hrycay EG, Bandiera SM (2012) The monooxygenase, peroxidase, and peroxygenase properties of cytochrome P450 Arch Biochem Biophys 522:71-89
214. Niraula NP, Kanth BK, Sohng JK, Oh TJ (2011) Hydrogen peroxide-mediated dealkylation of 7-ethoxycoumarin by cytochrome P450 (CYP107AJ1) from Streptomyces peucetius ATCC27952 Enzyme Microb Technol 48:181-186
215. Ogura H, Nishida CR, Hoch UR, Perera R, Dawson JH, Ortiz de Montellano PR (2004) EpoK, a cytochrome P450 involved in biosynthesis of the anticancer agents epothilones A and B Substratemediated rescue of a P450 enzyme Biochemistry 43:14712-14721
216. Cirino PC, Arnold FH (2003) A self-sufficient peroxide-driven hydroxylation biocatalyst Angew Chem Int Ed Engl 42:3299-3301
217. Cirino PC, Tang Y, Takahashi K, Tirrell DA, Arnold FH (2003) Global incorporation of norleucine in place of methionine in cytochrome P450 BM3 heme domain increases peroxygenase activity Biotechnol Bioeng 83:729-734
218. Gutteridge JM (1989) Iron and oxygen: a biologically damaging mixture Acta Paediatr Scand Suppl 361:78-85
219. Gutteridge JM (1990) Superoxide-dependent formation of hydroxyl radicals from ferric-complexes and hydrogen peroxide: an evaluation of fourteen iron chelators Free Radic Res Commun 9:119-125
220. Matsunaga I, Yokotani N, Gotoh O, Kusunose E, Yamada M, Ichihara K (1997) Molecular cloning and expression of fatty acid alpha-hydroxylase from Sphingomonas paucimobilis J Biol Chem 272:23592-23596
221. Matsunaga I, Ueda A, Fujiwara N, Sumimoto T, Ichihara K (1999) Characterization of the ybdT gene product of Bacillus subtilis: novel fatty acid betahydroxylating cytochrome P450 Lipids 34:841-846
222. Girhard M, Schuster S, Dietrich M, Durre P, Urlacher VB (2007) Cytochrome P450 monooxygenase from Clostridium acetobutylicum: a new alpha-fatty acid hydroxylase Biochem Biophys Res Commun 362:114-119
223. Fleming BD, Tian Y, Bell SG, Wong LL, Urlacher V, Hill HA (2003) Redox properties of cytochrome P450 BM3 measured by direct methods Eur J Biochem 270:4082-4088
224. Schneider E, Clark DS (2012) Cytochrome P450 (CYP) enzymes and the development of CYP biosensors Biosens Bioelectron 39:1-13
225. Shumyantseva V, Bulko T, Archakov A (2005) Electrochemical reduction of cytochrome P450 as an approach to the construction of biosensors and bioreactors J Inorg Biochem 99:1051-1063
226. Bistolas N, Wollenberger U, Jung C, Scheller F (2005) Cytochrome P450 biosensors-a review Biosens Bioelectron 20:2408-2423
227. Udit A, Gray H (2005) Electrochemistry of hemethiolate proteins Biochem Biophys Res Commun 338:470-476
228. Mayhew MP, Reipa V, Holden MJ, Vilker VL (2000) Improving the cytochrome P450 enzyme system for electrode-driven biocatalysis of styrene epoxidation Biotechnol Prog 16:610-616
229. Reipa V, Mayhew MP, Holden MJ, Vilker VL (2002) Redox control of the P450cam catalytic cycle: effects of Y96F active site mutation and binding of a non-natural substrate Chem Commun (Camb) 4:318-319
230. Reipa V, Mayhew MP, Vilker VL (1997) A direct electrode-driven P450 cycle for biocatalysis Proc Natl Acad Sci U S A 94:13554-13558
231. Estabrook RW, Faulkner KM, Shet MS, Fisher CW (1996) Application of electrochemistry for P450- catalyzed reactions Methods Enzymol 272:44-51
232. Estabrook RW, Shet MS, Fisher CW, Jenkins CM, Waterman MR (1996) The interaction of NADPHP450 reductase with P450: an electrochemical study of the role of the flavin mononucleotide-binding domain Arch Biochem Biophys 333:308-315
233. Faulkner KM, Shet MS, Fisher CW, Estabrook RW (1995) Electrocatalytically driven omega-hydroxylation of fatty acids using cytochrome P450 4A1 Proc Natl Acad Sci U S A 92:7705-7709
234. Udit AK, Arnold FH, Gray HB (2004) Cobaltocenemediated catalytic monooxygenation using holo and heme domain cytochrome P450 BM3 J Inorg Biochem 98:1547-1550
235. Shumyantseva VV, Bulko TV, Usanov SA, Schmid RD, Nicolini C, Archakov AI (2001) Construction and characterization of bioelectrocatalytic sensors based on cytochromes P450 J Inorg Biochem 87:185-190
236. Sadeghi SJ, Fantuzzi A, Gilardi G (2011) Breakthrough in P450 bioelectrochemistry and future perspectives Biochim Biophys Acta 1814:237-248
237. Kazlauskaite J, Westlake ACG, Wong L-L, Hill HAO (1996) Direct electrochemistry of cytochrome P450cam Chem Commun (Camb) 18: 2189-2190
238. Gray HB, Winkler JR (1996) Electron transfer in proteins Annu Rev Biochem 65:537-561
239. Shumyantseva VV, Ivanov YD, Bistolas N, Scheller FW, Archakov AI, Wollenberger U (2004) Direct electron transfer of cytochrome P450 2B4 at electrodes modified with nonionic detergent and colloidal clay nanoparticles Anal Chem 76:6046-6052
240. Cosnier S (1999) Biomolecule immobilization on electrode surfaces by entrapment or attachment to electrochemically polymerized films Biosens Bioelectron 14:443-456
241. Schuhmann W, Wohlschlager H, Huber J, Schmidt HL, Stadler H (1995) Development of an extremely flexible automatic analyzer with integrated biosensors for online control of fermentation processes Anal Chim Acta 315:113-122
242. Antonini M, Ghisellini P, Pastorino L, Paternolli C, Nicolini C (2003) Preliminary electrochemical characterisation of cytochrome P4501A2-clozapine interaction IEE Proc Nanobiotechnol 150:31-34
243. Guo YZ, Dong SJ (1997) Organic phase enzyme electrodes based on organohydrogel Anal Chem 69:1904-1908
244. Rusling JF (1998) Enzyme bioelectrochemistry in cast biomembrane-like films Acc Chem Res 31:363-369
245. Zu X, Lu Z, Zhang Z, Schenkman JB, Rusling JF (1999) Electroenzyme catalyzed oxidation of styrene and cis-β-methylstyrene using thin films of cytochrome P450cam and myoglobin Langmuir 15:7372-7377
246. Munge B, Estavillo C, Schenkman JB, Rusling JF (2003) Optimization of electrochemical and peroxide- driven oxidation of styrene with ultrathin polyion films containing cytochrome P450cam and myoglobin Chembiochem 4:82-89
247. Lvov YM, Lu Z, Schenkman JB, Zu X, Rusling JF (1998) Direct electrochemistry of myoglobin and cytochrome P450cam in alternate layer-by-layer films with DNA and other polyions J Amer Chem Soc 120:4073-4080
248. Estavillo C, Lu Z, Jansson I, Schenkman JB, Rusling JF (2003) Epoxidation of styrene by human cyt P450 1A2 by thin film electrolysis and peroxide activation compared to solution reactions Biophys Chem 104:291-296
249. Holtmann D, Mangold KM, Schrader J (2009) Entrapment of cytochrome P450 BM3 in polypyrrole for electrochemically-driven biocatalysis Biotechnol Lett 31:765-770
250. 4 J Am Chem Soc 126:8632-8633
251. Sultana N, Schenkman JB, Rusling JF (2005) Protein film electrochemistry of microsomes genetically enriched in human cytochrome P450 monooxygenases J Am Chem Soc 127:13460-13461
252. Iwuoha EI, Joseph S, Zhang Z, Smyth MR, Fuhr U, Ortiz de Montellano PR (1998) Drug metabolism biosensors: electrochemical reactivities of cytochrome P450cam immobilised in synthetic vesicular systems J Pharm Biomed Anal 17:1101-1110
253. Joseph S, Rusling JF, Lvov YM, Friedberg T, Fuhr U (2003) An amperometric biosensor with human CYP3A4 as a novel drug screening tool Biochem Pharmacol 65:1817-1826
254. Ferrero VE, Andolfi L, Di Nardo G, Sadeghi SJ, Fantuzzi A, Cannistraro S, Gilardi G (2008) Protein and electrode engineering for the covalent immobilization of P450 BMP on gold Anal Chem 80:8438- 8446
255. Shumyantseva VV, Bulko TV, Kuznetsova GP, Samenkova NF, Archakov AI (2009) Electrochemistry of cytochromes P450: analysis of current-voltage characteristics of electrodes with immobilized cytochromes P450 for the screening of substrates and inhibitors Biochemistry (Mosc) 74:438-444
256. Fantuzzi A, Capria E, Mak LH, Dodhia VR, Sadeghi SJ, Collins S, Somers G, Huq E, Gilardi G (2010) An electrochemical microfluidic platform for human P450 drug metabolism profiling Anal Chem 82:10222-10227
257. Panicco P, Dodhia VR, Fantuzzi A, Gilardi G (2011) Enzyme-based amperometric platform to determine the polymorphic response in drug metabolism by cytochromes P450 Anal Chem 83:2179-2186
258. Fantuzzi A, Mak LH, Capria E, Dodhia V, Panicco P, Collins S, Gilardi G (2011) A new standardized electrochemical array for drug metabolic profiling with human cytochromes P450 Anal Chem 83:3831- 3839
259. Sadeghi SJ, Ferrero S, Di Nardo G, Gilardi G (2012) Drug-drug interactions and cooperative effects detected in electrochemically driven human cytochrome P450 3A4 Bioelectrochemistry 86:87-91
260. Bommarius AS, Schwarm M, Drauz K (1998) Biocatalysis to amino acid-based chiral pharmaceuticals- examples and perspectives J Mol Catal B Enzym 5:1-11
261. Falck JR, Reddy YK, Haines DC, Reddy KM, Krishna UM, Graham S, Murry B, Peterson JA (2001) Practical, enantiospecific synthesis of 14,15- EET and leukotoxin B (vernolic acid) Tetrahedron Lett 42:4131-4133
262. Tishkov VI, Popov VO (2006) Protein engineering of formate dehydrogenase Biomol Eng 23:89-110
263. Tishkov VI, Galkin AG, Marchenko GN, Egorova OA, Sheluho DV, Kulakova LB, Dementieva LA, Egorov AM (1993) Catalytic properties and stability of a Pseudomonas sp 101 formate dehydrogenase mutants containing Cys-255-Ser and Cys-255-Met replacements Biochem Biophys Res Commun 192:976-981
264. + FEBS J 275:3859-3869
265. + cofactor recycling system: towards a technical application of heme-containing monooxygenases in fine chemical synthesis Adv Synth Catal 345:802-810
266. Kuehnel K, Maurer SC, Galeyeva Y, Frey W, Laschat S, Urlacher VB (2007) Hydroxylation of dodecanoic acid and (2R,4R,6R,8R)-tetramethyldecanol on a preparative scale using an NADH-dependent CYP102A1 mutant Adv Synth Catal 349:1451-1461
267. Maurer SC, Kuhnel K, Kaysser LA, Eiben S, Schmid RD, Urlacher VB (2005) Catalytic hydroxylation in biphasic systems using CYP102A1 mutants Adv Synth Catal 347:1090-1098
268. Michizoe J, Ichinose H, Kamiya N, Maruyama T, Goto M (2005) Functionalization of the cytochrome P450cam monooxygenase system in the cell-like aqueous compartments of water-in-oil emulsions J Biosci Bioeng 99:12-17
269. Kubo T, Peters MW, Meinhold P, Arnold FH (2006) Enantioselective epoxidation of terminal alkenes to (R)- and (S)-epoxides by engineered cytochromes P450 BM3 Chemistry 12:1216-1220
270. Mouri T, Shimizu T, Kamiya N, Goto M, Ichinose H (2009) Design of a cytochrome P450 BM3 reaction system linked by two-step cofactor regeneration catalyzed by a soluble transhydrogenase and glycerol dehydrogenase Biotechnol Prog 25:1372-1378
271. Denard CA, Huang H, Bartlett MJ, Lu L, Tan Y, Zhao H, Hartwig JF (2014) Cooperative tandem ca talysis by an organometallic complex and a metalloenzyme Angew Chem Int Ed Engl 53:465-469
272. Relyea HA, van der Donk WA (2005) Mechanism and applications of phosphite dehydrogenase Bioorg Chem 33:171-189
273. Vrtis JM, White AK, Metcalf WW, van der Donk WA (2002) Phosphite dehydrogenase: a versatile cofactor-regeneration enzyme Angew Chem Int Ed Engl 41:3257-3259
274. Woodyer R, van der Donk WA, Zhao H (2003) Relaxing the nicotinamide cofactor specificity of phosphite dehydrogenase by rational design Biochemistry 42:11604-11614
275. Shumyantseva VV, Bulko TV, Schmid RD, Archakov AI (2002) Photochemical properties of a riboflavins/cytochrome P450 2B4 complex Biosens Bioelectron 17:233-238
276. Girhard M, Kunigk E, Tihovsky S, Shumyantseva VV, Urlacher VB (2013) Light-driven biocatalysis with cytochrome P450 peroxygenases Biotechnol Appl Biochem 60:111-118
277. Hu YZ, Tsukiji S, Shinkai S, Oishi S, Hamachi I (2000) Construction of artificial photosynthetic reaction centers on a protein surface: vectorial, multistep, and proton-coupled electron transfer for long-lived charge separation J Am Chem Soc 122:241-253
278. Immoos CE, Di Bilio AJ, Cohen MS, Van der Veer W, Gray HB, Farmer PJ (2004) Electron-transfer chemistry of Ru-linker-(Heme)-modified myoglobin: rapid intraprotein reduction of a photogenerated porphyrin cation radical Inorg Chem 43:3593-3596
279. Ener ME, Lee YT, Winkler JR, Gray HB, Cheruzel L (2010) Photooxidation of cytochrome P450 BM3 Proc Natl Acad Sci U S A 107:18783-18786
280. Tran NH, Nguyen D, Dwaraknath S, Mahadevan S, Chavez G, Nguyen A, Dao T, Mullen S, Nguyen TA, Cheruzel LE (2013) An efficient light-driven P450 BM3 biocatalyst J Am Chem Soc 135:14484-14487
281. Kim Y-S, Hara M, Ikebukuro K, Miyake J, Ohkawa H, Karube I (1996) Photo-induced activation of cytochrome P450/reductase fusion enzyme coupled with spinach chloroplasts Biotechnol Tech 10:717- 720
282. Hara M, Iazvovskaia S, Ohkawa H, Asada Y, Miyake J (1999) Immobilization of P450 monooxygenase and chloroplast for use in light-driven bioreactors J Biosci Bioeng 87:793-797
283. Jensen K, Jensen PE, Moller BL (2011) Light-driven cytochrome P450 hydroxylations ACS Chem Biol 6:533-539
284. Jensen K, Johnston JB, de Montellano PR, Moller BL (2012) Photosystem I from plants as a bacterial cytochrome P450 surrogate electron donor: terminal hydroxylation of branched hydrocarbon chains Biotechnol Lett 34:239-245
285. Jensen K, Jensen PE, Moller BL (2012) Light-driven chemical synthesis Trends Plant Sci 17:60-63
286. Meyer D, Buhler B, Schmid A (2006) Process and catalyst design objectives for specific redox biocatalysis Adv Appl Microbiol 59:53-91
287. Evans WE, Relling MV (1999) Pharmacogenomics: translating functional genomics into rational therapeutics Science 286:487-491
288. Guengerich FP (2003) Cytochromes P450, drugs, and diseases Mol Interv 3:194-204
289. Gillam EM (2007) Extending the capabilities of nature's most versatile catalysts: directed evolution of mammalian xenobiotic-metabolizing P450s Arch Biochem Biophys 464:176-186
290. Gillam EM, Guo Z, Martin MV, Jenkins CM, Guengerich FP (1995) Expression of cytochrome P450 2D6 in Escherichia coli, purification, and spectral and catalytic characterization Arch Biochem Biophys 319:540-550
291. Purnapatre K, Khattar SK, Saini KS (2008) Cytochrome P450s in the development of target-based anticancer drugs Cancer Lett 259:1-15
292. Barnes HJ, Arlotto MP, Waterman MR (1991) Expression and enzymatic activity of recombinant cytochrome P450 17 alpha-hydroxylase in Escherichia coli Proc Natl Acad Sci U S A 88:5597-5601
293. 2-terminal region on localization in cytosol and membranes Proc Natl Acad Sci U S A 90:2651-2655
294. Pikuleva IA, Bjorkhem I, Waterman MR (1997) Expression, purification, and enzymatic properties of recombinant human cytochrome P450c27 (CYP27) Arch Biochem Biophys 343:123-130
295. von Wachenfeldt C, Richardson TH, Cosme J, Johnson EF (1997) Microsomal P450 2C3 is expressed as a soluble dimer in Escherichia coli following modifications of its N-terminus Arch Biochem Biophys 339:107-114
296. Wu ZL, Bartleson CJ, Ham AJ, Guengerich FP (2006) Heterologous expression, purification, and properties of human cytochrome P450 27C1 Arch Biochem Biophys 445:138-146
297. Yano JK, Wester MR, Schoch GA, Griffin KJ, Stout CD, Johnson EF (2004) The structure of human microsomal cytochrome P450 3A4 determined by Xray crystallography to 2 0 angstrom resolution Drug Metab Rev 36:345-345
298. Yip SSM, Coulombe RA (2006) Molecular cloning and expression of a novel cytochrome P450 from turkey liver with aflatoxin B-1 oxidizing activity Chem Res Toxicol 19:30-37
299. Pritchard MP, Ossetian R, Li DN, Henderson CJ, Burchell B, Wolf CR, Friedberg T (1997) A general strategy for the expression of recombinant human cytochrome P450s in Escherichia coli using bacterial signal peptides: expression of CYP3A4, CYP2A6, and CYP2E1 Arch Biochem Biophys 345:342-354
300. Cosme J, Johnson EF (2000) Engineering microsomal cytochrome P450 2C5 to be a soluble, monomeric enzyme Mutations that alter aggregation, phospholipid dependence of catalysis, and membrane binding J Biol Chem 275:2545-2553
301. Kumar S, Halpert JR (2005) Use of directed evolution of mammalian cytochromes P450 for investigating the molecular basis of enzyme function and generating novel biocatalysts Biochem Biophys Res Commun 338:456-464
302. Kumar S, Zhao Y, Sun L, Negi SS, Halpert JR, Muralidhara BK (2007) Rational engineering of human cytochrome P450 2B6 for enhanced expression and stability: importance of a Leu264Phe substitution Mol Pharmacol 72:1191-1199
303. Schroer K, Kittelmann M, Lutz S (2010) Recombinant human cytochrome P450 monooxygenases for drug metabolite synthesis Biotechnol Bioeng 106:699-706
304. Rushmore TH, Reider PJ, Slaughter D, Assang C, Shou M (2000) Bioreactor systems in drug metabolism: synthesis of cytochrome P450-generated metabolites Metab Eng 2:115-125
305. Guengerich FP (2002) Cytochrome P450 enzymes in the generation of commercial products Nat Rev Drug Discov 1:359-366
306. Hanlon SP, Friedberg T, Wolf CR, Ghisalba O, Kittelmann M (2007) Recombinant yeast and bacteria that express human P450s: Bioreactors for drug discovery, development and biotechnology In: Schmid RD, Urlacher VB (eds) Modern biooxidations Enzymes, reactions and applications Wiley, Weinheim, pp 233-252
307. Zollner A, Buchheit D, Meyer MR, Maurer HH, Peters FT, Bureik M (2010) Production of human phase 1 and 2 metabolites by whole-cell biotransformation with recombinant microbes Bioanalysis 2:1277-1290
308. Neunzig I, Widjaja M, Peters FT, Maurer HH, Hehn A, Bourgaud F, Bureik M (2013) Coexpression of CPR from various origins enhances biotransformation activity of human CYPs in S. pombe Appl Biochem Biotechnol 170:1751-1766
309. Ghisalba O, Kittelmann M (2007) Preparation of drug metabolites using fungal and bacterial strains In: Schmid RD, Urlacher VB (eds) Modern biooxidation Wiley, Weinheim, pp 211-232
310. Di Nardo G, Gilardi G (2012) Optimization of the bacterial cytochrome P450 BM3 system for the production of human drug metabolites Int J Mol Sci 13:15901-15924
311. Lussenburg BM, Babel LC, Vermeulen NP, Commandeur JN (2005) Evaluation of alkoxyresorufins as fluorescent substrates for cytochrome P450 BM3 and site-directed mutants Anal Biochem 341:148- 155
312. Sawayama AM, Chen MM, Kulanthaivel P, Kuo MS, Hemmerle H, Arnold FH (2009) A panel of cytochrome P450 BM3 variants to produce drug metabolites and diversify lead compounds Chemistry 15:11723-11729
313. Boerma JS, Vermeulen NP, Commandeur JN (2011) Application of CYP102A1M11H as a tool for the generation of protein adducts of reactive drug metabolites Chem Res Toxicol 24:1263-1274
314. Reinen J, van Leeuwen JS, Li Y, Sun L, Grootenhuis PD, Decker CJ, Saunders J, Vermeulen NP, Commandeur JN (2011) Efficient screening of cytochrome P450 BM3 mutants for their metabolic activity and diversity toward a wide set of drug-like molecules in chemical space Drug Metab Dispos 39:1568-1576
315. Vottero E, Rea V, Lastdrager J, Honing M, Vermeulen NP, Commandeur JN (2011) Role of residue 87 in substrate selectivity and regioselectivity of drugmetabolizing cytochrome P450 CYP102A1 M11 J Biol Inorg Chem 16:899-912
316. Kleser M, Hannemann F, Hutter M, Zapp J, Bernhardt R (2012) CYP105A1 mediated 3-hydroxylation of glimepiride and glibenclamide using a recombinant Bacillus megaterium whole-cell catalyst J Biotechnol 157:405-412
317. Weis R, Winkler M, Schittmayer M, Kambourakis S, Vink M, Rozzell JD, Glieder A (2009) A diversified library of bacterial and fungal bifunctional cytochrome P450 enzymes for drug metabolite synthesis Adv Synth Catal 351:2140-2146
318. Donova MV, Egorova OV (2012) Microbial steroid transformations: current state and prospects Appl Microbiol Biotechnol 94:1423-1447
319. Baker ME (2011) Origin and diversification of steroids: co-evolution of enzymes and nuclear receptors Mol Cell Endocrinol 334:14-20
320. Rupprecht R (2003) Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties Psychoneuroendocrinology 28:139-168
321. Schule C, Eser D, Baghai TC, Nothdurfter C, Kessler JS, Rupprecht R (2011) Neuroactive steroids in affective disorders: target for novel antidepressant or anxiolytic drugs? Neuroscience 191:55-77
322. Peterson DH, Murray HC, Eppstein SH, Reineke LM, Weintraub A, Meister PD, Leigh HM (1952) Microbiological transformations of steroids 1 Introduction of oxygen at carbon-11 of progesterone J Am Chem Soc 74:5933-5936
323. Hogg JA (1992) Steroids, the steroid community, and Upjohn in perspective: a profile of innovation Steroids 57:593-616
324. Petzoldt K, Annen K, Laurent H, Wiechert R (1982) Process for the preparation of 11-beta-hydroxy steroids Berlin, Germany (Patent 4,353,985, Schering Aktiengesellschaft)
325. Hanson JR (2005) Steroids: reactions and partial synthesis Nat Prod Rep 22:104-110
326. Laveaga GS (2005) Uncommon trajectories: steroid hormones, Mexican peasants, and the search for a wild yam Stud Hist Philos Biol Biomed Sci 36:743- 760
327. Agematu H, Matsumoto N, Fujii Y, Kabumoto H, Doi S, Machida K, Ishikawa J, Arisawa A (2006) Hydroxylation of testosterone by bacterial cytochromes P450 using the Escherichia coli expression system Biosci Biotechnol Biochem 70:307-311
328. Arisawa A, Agematu H (2007) A modular approach to biotransformation using microbial cytochrome P450 monooxygenases In: Schmid RD, Urlacher VB (eds) Modern biooxidation, 1st edn Wiley- VCH, Weinheim, pp 177-192
329. Uhia I, Galan B, Kendall SL, Stoker NG, Garcia JL (2012) Cholesterol metabolism in Mycobacterium smegmatis Environ Microbiol Rep 4:168-182
330. van der Geize R, Yam K, Heuser T, Wilbrink MH, Hara H, Anderton MC, Sim E, Dijkhuizen L, Davies JE, Mohn WW, Eltis LD (2007) A gene cluster encoding cholesterol catabolism in a soil actinomycete provides insight into Mycobacterium tuberculosis survival in macrophages Proc Natl Acad Sci U S A 104:1947-1952
331. Bracco P, Janssen DB, Schallmey A (2013) Selective steroid oxyfunctionalisation by CYP154C5, a bacterial cytochrome P450 Microb Cell Fact 12:95
332. Makino T, Katsuyama Y, Otomatsu T, Misawa N, Ohnishi Y (2014) Regio- and stereospecific hydroxylation of various steroids at the 16alpha position of the D ring by the Streptomyces griseus cytochrome P450 CYP154C3 Appl Environ Microbiol 80:1371-1379
333. Geier M, Braun A, Fladischer P, Stepniak P, Rudroff F, Hametner C, Mihovilovic MD, Glieder A (2013) Double site saturation mutagenesis of the human cytochrome P450 2D6 results in regioselective steroid hydroxylation FEBS J 280:3094-3108
334. Goetschel R, Bar R (1992) Formation of mixed crystals in microbial conversion of sterols and steroids Enzyme Microb Technol 14:462-469
335. Manosroi A, Saowakhon S, Manosroi J (2008) Enhancement of androstadienedione production from progesterone by biotransformation using the hydroxypropyl- beta-cyclodextrin complexation technique J Steroid Biochem Mol Biol 108:132-136
336. Roglic U, Znidarsic-Plazl P, Plazl I (2005) The influence of beta-cyclodextrin on the kinetics of progesterone transformation by Rhizopus nigricans Biocatal Biotransform 23:299-305
337. Lam KS (2010) Application of whole-cell biotransformation in the pharmaceutical industry In: Tao J, Lin G-Q, Liese A (eds) Biocatalysis for the pharmaceutical industry: discovery, development, and manufacturing Wiley, New York, pp 213-227
338. Braun A, Geier M, Buhler B, Schmid A, Mauersberger S, Glieder A (2012) Steroid biotransformations in biphasic systems with Yarrowia lipolytica expressing human liver cytochrome P450 genes Microb Cell Fact 11:106
339. Duport C, Spagnoli R, Degryse E, Pompon D (1998) Self-sufficient biosynthesis of pregnenolone and progesterone in engineered yeast Nat Biotechnol 16:186-189
340. Szczebara FM, Chandelier C, Villeret C, Masurel A, Bourot S, Duport C, Blanchard S, Groisillier A, Testet E, Costaglioli P, Cauet G, Degryse E, Balbuena D, Winter J, Achstetter T, Spagnoli R, Pompon D, Dumas B (2003) Total biosynthesis of hydrocortisone from a simple carbon source in yeast Nat Biotechnol 21:143-149
341. Serizawa N (1997) Development of two-step fermentation- based production of pravastatin, a HMGCoA reductase J Synth Org Chem Jpn 55:334-338
342. Watanabe I, Nara F, Serizawa N (1995) Cloning, characterization and expression of the gene encoding cytochrome P-450sca-2 from Streptomyces carbophilus involved in production of pravastatin, a specific HMG-CoA reductase inhibitor Gene 163:81-85
343. Sakaki T (2012) Practical application of cytochrome P450 Biol Pharm Bull 35:844-849
344. Watanabe I, Serizawa N (1998) Molecular approaches for production of pravastatin, a HMG-CoA reductase inhibitor: transcriptional regulation of the cytochrome p450sca gene from Streptomyces carbophilus by ML-236B sodium salt and phenobarbital Gene 210:109-116
345. Hosobuchi M, Kurosawa K, Yoshikawa H (1993) Application of computer to monitoring and control of fermentation process: microbial conversion of ML-236B Na to pravastatin Biotechnol Bioeng 42:815-820
346. Park JW, Lee JK, Kwon TJ, Yi DH, Kim YJ, Moon SH, Suh HH, Kang SM, Park YI (2003) Bioconversion of compactin into pravastatin by Streptomyces sp Biotechnol Lett 25:1827-1831
347. Peng Y, Yashphe J, Demain AL (1997) Biotransformation of compactin to pravastatin by Actinomadura sp 2966 J Antibiot (Tokyo) 50:1032-1035
348. Chen CH, Hu HY, Cho YC, Hsu WH (2006) Screening of compactin-resistant microorganisms capable of converting compactin to pravastatin Curr Microbiol 53:108-112
349. Ba L, Li P, Zhang H, Duan Y, Lin Z (2013) Semirational engineering of cytochrome P450sca-2 in a hybrid system for enhanced catalytic activity: insights into the important role of electron transfer Biotechnol Bioeng 110:2815-2825
350. Fujii T, Fujii Y, Machida K, Ochiai A, Ito M (2009) Efficient biotransformations using Escherichia coli with tolC acrAB mutations expressing cytochrome P450 genes Biosci Biotechnol Biochem 73:805- 810
351. Grant C, Woodley JM, Baganz F (2011) Whole-cell bio-oxidation of n-dodecane using the alkane hydroxylase system of P. putida GPo1 expressed in E. coli Enzyme Microb Technol 48:480-486
352. Schneider S, Wubbolts MG, Sanglard D, Witholt B (1998) Biocatalyst engineering by assembly of fatty acid transport and oxidation activities for In vivo application of cytochrome P450 BM3 monooxygenase Appl Environ Microbiol 64:3784-3790
353. Julsing MK, Schrewe M, Cornelissen S, Hermann I, Schmid A, Buhler B (2012) Outer membrane protein AlkL boosts biocatalytic oxyfunctionalization of hydrophobic substrates in Escherichia coli Appl Environ Microbiol 78:5724-5733
354. Cornelissen S, Julsing MK, Volmer J, Riechert O, Schmid A, Buhler B (2013) Whole-cell-based CYP153A6- catalyzed (S)-limonene hydroxylation efficiency depends on host background and profits from monoterpene uptake via AlkL Biotechnol Bioeng 110:1282-1292
355. Scheps D, Honda Malca S, Richter SM, Marisch K, Nestl BM, Hauer B (2013) Synthesis of omegahydroxy dodecanoic acid based on an engineered CYP153A fusion construct Microb Biotechnol 6:694-707
356. Ruijssenaars HJ, Sperling EM, Wiegerinck PH, Brands FT, Wery J, de Bont JA (2007) Testosterone 15beta-hydroxylation by solvent tolerant Pseudomonas putida S12 J Biotechnol 131:205-208
357. Siriphongphaew A, Pisnupong P, Wongkongkatep J, Inprakhon P, Vangnai AS, Honda K, Ohtake H, Kato J, Ogawa J, Shimizu S, Urlacher VB, Schmid RD, Pongtharangkul T (2012) Development of a wholecell biocatalyst co-expressing P450 monooxygenase and glucose dehydrogenase for synthesis of epoxyhexane Appl Microbiol Biotechnol 95:357-367
358. Gavira C, Hofer R, Lesot A, Lambert F, Zucca J, Werck-Reichhart D (2013) Challenges and pitfalls of P450-dependent (+)-valencene bioconversion by Saccharomyces cerevisiae Metab Eng 18:25-35
359. Girhard M, Machida K, Itoh M, Schmid RD, Arisawa A, Urlacher VB (2009) Regioselective biooxidation of (+)-valencene by recombinant E. coli expressing CYP109B1 from Bacillus subtilis in a two-liquid-phase system Microb Cell Fact 8:36, 1-13
360. Buhler B, Park JB, Blank LM, Schmid A (2008) NADH availability limits asymmetric biocatalytic epoxidation in a growing recombinant Escherichia coli strain Appl Environ Microbiol 74:1436-1446
361. Mouri T, Michizoe J, Ichinose H, Kamiya N, Goto M (2006) A recombinant Escherichia coli whole cell biocatalyst harboring a cytochrome P450cam monooxygenase system coupled with enzymatic cofactor regeneration Appl Microbiol Biotechnol 2:514-520
362. Schewe H, Kaup BA, Schrader J (2008) Improvement of P450(BM-3) whole-cell biocatalysis by integrating heterologous cofactor regeneration combining glucose facilitator and dehydrogenase in E. coli Appl Microbiol Biotechnol 78:55-65
363. Schewe H, Holtmann D, Schrader J (2009) P450(BM3)-catalyzed whole-cell biotransformation of alpha-pinene with recombinant Escherichia coli in an aqueous-organic two-phase system Appl Microbiol Biotechnol 83:849-857
364. Zehentgruber D, Hannemann F, Bleif S, Bernhardt R, Lutz S (2010) Towards preparative scale steroid hydroxylation with cytochrome P450 monooxygenase CYP106A2 Chembiochem 11:713-721
365. Schmidt BM, Ribnicky DM, Lipsky PE, Raskin I (2007) Revisiting the ancient concept of botanical therapeutics Nat Chem Biol 3:360-366
366. Newman DJ, Cragg GM (2012) Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod 75:311-335
367. Chemler JA, Koffas MAG (2008) Metabolic engineering for plant natural product biosynthesis in microbes Curr Opin Biotechnol 19:597-605
368. Marienhagen J, Bott M (2013) Metabolic engineering of microorganisms for the synthesis of plant natural products J Biotechnol 163:166-178
369. Mora-Pale M, Sanchez-Rodriguez SP, Linhardt RJ, Dordick JS, Koffas MAG (2014) Biochemical strategies for enhancing the in vivo production of natural products with pharmaceutical potential Curr Opin Biotechnol 25:86-94
370. Siddiqui MS, Thodey K, Trenchard I, Smolke CD (2012) Advancing secondary metabolite biosynthesis in yeast with synthetic biology tools FEMS Yeast Res 12:144-170
371. Newhouse T, Baran PS, Hoffmann RW (2009) The economies of synthesis Chem Soc Rev 38:3010- 3021
372. Nelson D, Werck-Reichhart D (2011) A P450-centric view of plant evolution Plant J 66:194-211
373. Facchini PJ, Bohlmann J, Covello PS, De Luca V, Mahadevan R, Page JE, Ro D-K, Sensen CW, Storms R, Martin VJJ, Synthetic biosystems for the production of high-value plant metabolites Trends Biotechnol 30:127-131
374. Heinig U, Jennewein S (2009) Taxol: a complex diterpenoid natural product with an evolutionarily obscure origin Afr J Biotechnol 8:1370-1385
375. Chang MCY, Keasling JD (2006) Production of isoprenoid pharmaceuticals by engineered microbes Nat Chem Biol 2:674-681
376. Moses T, Pollier J, Thevelein JM, Goossens A (2013) Bioengineering of plant (tri)terpenoids: from metabolic engineering of plants to synthetic biology in vivo and in vitro New Phytol 200:27-43
377. Duan H, Schuler M (2006) Heterologous expression and strategies for encapsulation of membrane-localized plant P450s Phytochem Rev 5:507-523
378. Weitzel C, Simonsen H (2013) Cytochrome P450 enzymes involved in the biosynthesis of monoand sesquiterpenes Phytochem Rev doi:10 1007/s11101-013-9280-x
379. Anthony JR, Anthony LC, Nowroozi F, Kwon G, Newman JD, Keasling JD (2009) Optimization of the mevalonate-based isoprenoid biosynthetic pathway in Escherichia coli for production of the antimalarial drug precursor amorpha-4,11-diene Metab Eng 11:13-19
380. Farmer WR, Liao JC (2001) Precursor balancing for metabolic engineering of lycopene production in Escherichia coli Biotechnol Prog 17:57-61
381. Gruchattka E, Hadicke O, Klamt S, Schutz V, Kayser O (2013) In silico profiling of Escherichia coli and Saccharomyces cerevisiae as terpenoid factories Microb Cell Fact 12:84
382. Martin VJJ, Pitera DJ, Withers ST, Newman JD, Keasling JD (2003) Engineering a mevalonate pathway in Escherichia coli for production of terpenoids Nat Biotech 21:796-802
383. Morrone D, Lowry L, Determan M, Hershey D, Xu M, Peters R (2010) Increasing diterpene yield with a modular metabolic engineering system in E. coli: comparison of MEV and MEP isoprenoid precursor pathway engineering Appl Microbiol Biotechnol 85:1893-1906
384. Partow S, Siewers V, Daviet L, Schalk M, Nielsen J (2012) Reconstruction and evaluation of the synthetic bacterial MEP pathway in Saccharomyces cerevisiae PLoS One 7:e52498
385. Pitera DJ, Paddon CJ, Newman JD, Keasling JD (2007) Balancing a heterologous mevalonate pathway for improved isoprenoid production in Escherichia coli Metab Eng 9:193-207
386. Yuan LZ, Rouvière PE, LaRossa RA, Suh W (2006) Chromosomal promoter replacement of the isoprenoid pathway for enhancing carotenoid production in E. coli Metab Eng 8:79-90
387. Carter OA, Peters RJ, Croteau R (2003) Monoterpene biosynthesis pathway construction in Escherichia coli Phytochemistry 64:425-433
388. Alonso-Gutierrez J, Chan R, Batth TS, Adams PD, Keasling JD, Petzold CJ, Lee TS (2013) Metabolic engineering of Escherichia coli for limonene and perillyl alcohol production Metab Eng 19:33-41
389. Mau CJD, Karp F, Ito M, Honda G, Croteau RB (2010) A candidate cDNA clone for (-)-limonene- 7-hydroxylase from Perilla frutescens Phytochemistry 71:373-379
390. Cankar K, van Houwelingen A, Bosch D, Sonke T, Bouwmeester H, Beekwilder J (2011) A chicory cytochrome P450 monooxygenase CYP71AV8 for the oxidation of (+)-valencene FEBS Lett 585:178-182
391. Cankar K, van Houwelingen A, Goedbloed M, Renirie R, de Jong RM, Bouwmeester H, Bosch D, Sonke T, Beekwilder J (2014) Valencene oxidase CYP706M1 from Alaska cedar (Callitropsis nootkatensis) FEBS Lett 588:1001-1007
392. Harada H, Shindo K, Iki K, Teraoka A, Okamoto S, Yu F, Hattan J-i, Utsumi R, Misawa N (2011) Efficient functional analysis system for cyanobacterial or plant cytochromes P450 involved in sesquiterpene biosynthesis Appl Microbiol Biotechnol 90:467-476
393. Yu F, Okamoto S, Harada H, Yamasaki K, Misawa N, Utsumi R (2011) Zingiber zerumbet CYP71BA1 catalyzes the conversion of α-humulene to 8-hydroxy-α-humulene in zerumbone biosynthesis. Cell Mol Life Sci 68:1033-1040
394. WHO (2006) Guidelines for the treatment of malaria World Health Organization, Geneva
395. Paddon CJ, Westfall PJ, Pitera DJ, Benjamin K, Fisher K, McPhee D, Leavell MD, Tai A, Main A, Eng D, Polichuk DR, Teoh KH, Reed DW, Treynor T, Lenihan J, Fleck M, Bajad S, Dang G, Dengrove D, Diola D, Dorin G, Ellens KW, Fickes S, Galazzo J, Gaucher SP, Geistlinger T, Henry R, Hepp M, Horning T, Iqbal T, Jiang H, Kizer L, Lieu B, Melis D, Moss N, Regentin R, Secrest S, Tsuruta H, Vazquez R, Westblade LF, Xu L, Yu M, Zhang Y, Zhao L, Lievense J, Covello PS, Keasling JD, Reiling KK, Renninger NS, Newman JD (2013) Highlevel semi-synthetic production of the potent antimalarial artemisinin Nature 496:528-532
396. Teoh KH, Polichuk DR, Reed DW, Covello PS (2009) Molecular cloning of an aldehyde dehydrogenase implicated in artemisinin biosynthesis in Artemisia annua Botany 87:635-642
397. Cyr A, Wilderman PR, Determan M, Peters RJ (2007) A modular approach for facile biosynthesis of labdane-related diterpenes J Am Chem Soc 129:6684-6685
398. Swaminathan S, Morrone D, Wang Q, Fulton DB, Peters RJ (2009) CYP76M7 is an ent-cassadiene C11α-hydroxylase defining a second multifunctional diterpenoid biosynthetic gene cluster in rice Plant Cell 21:3315-3325
399. Wang Q, Hillwig ML, Peters RJ (2011) CYP99A3: functional identification of a diterpene oxidase from the momilactone biosynthetic gene cluster in rice Plant J 65:87-95
400. Wu Y, Hillwig ML, Wang Q, Peters RJ (2011) Parsing a multifunctional biosynthetic gene cluster from rice: biochemical characterization of CYP71Z6 & 7 FEBS Lett 585:3446-3451
401. Guo J, Zhou YJ, Hillwig ML, Shen Y, Yang L, Wang Y, Zhang X, Liu W, Peters RJ, Chen X, Zhao ZK, Huang L (2013) CYP76AH1 catalyzes turnover of miltiradiene in tanshinones biosynthesis and enables heterologous production of ferruginol in yeasts Proc Natl Acad Sci U S A 110:12108-12113
402. Ajikumar PK, Xiao WH, Tyo KE, Wang Y, Simeon F, Leonard E, Mucha O, Phon TH, Pfeifer B, Stephanopoulos G (2010) Isoprenoid pathway optimization for Taxol precursor overproduction in Escherichia coli Science 330:70-74
403. Jiang M, Stephanopoulos G, Pfeifer B (2012) Downstream reactions and engineering in the microbially reconstituted pathway for Taxol Appl Microbiol Biotechnol 94:841-849
404. Liby KT, Yore MM, Sporn MB (2007) Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer Nat Rev Cancer 7:357-369
405. Fukushima EO, Seki H, Ohyama K, Ono E, Umemoto N, Mizutani M, Saito K, Muranaka T (2011) CYP716A subfamily members are multifunctional oxidases in triterpenoid biosynthesis Plant Cell Physiol 52:2050-2061
406. Fukushima EO, Seki H, Sawai S, Suzuki M, Ohyama K, Saito K, Muranaka T (2013) Combinatorial biosynthesis of legume natural and rare triterpenoids in engineered yeast Plant Cell Physiol 54:740-749
407. Castillo DA, Kolesnikova MD, Matsuda SPT (2013) An effective strategy for exploring unknown metabolic pathways by genome mining J Am Chem Soc 135:5885-5894
408. Dai Z, Wang B, Liu Y, Shi M, Wang D, Zhang X, Liu T, Huang L, Zhang X (2014) Producing aglycons of ginsenosides in bakers' yeast Sci Rep 4:3698 doi:10 1038/srep0369
409. Quinlan RF, Jaradat TT, Wurtzel ET (2007) Escherichia coli as a platform for functional expression of plant P450 carotene hydroxylases Arch Biochem Biophys 458:146-157
410. Yan Y, Kohli A, Koffas MAG (2005) Biosynthesis of natural flavanones in Saccharomyces cerevisiae Appl Environ Microbiol 71:5610-5613
411. Leonard E, Yan Y, Lim KH, Koffas MAG (2005) Investigation of two distinct flavone synthases for plant-specific flavone biosynthesis in Saccharomyces cerevisiae Appl Environ Microbiol 71:8241- 8248
412. Leonard E, Yan Y, Koffas MAG (2006) Functional expression of a P450 flavonoid hydroxylase for the biosynthesis of plant-specific hydroxylated flavonols in Escherichia coli Metab Eng 8:172-181
413. Grubb CD, Abel S (2006) Glucosinolate metabolism and its control Trends Plant Sci 11:89-100
414. Mikkelsen MD, Buron LD, Salomonsen B, Olsen CE, Hansen BG, Mortensen UH, Halkier BA (2012) Microbial production of indolylglucosinolate through engineering of a multi-gene pathway in a versatile yeast expression platform Metab Eng 14:104-111
415. Hawkins KM, Smolke CD (2008) Production of benzylisoquinoline alkaloids in Saccharomyces cerevisiae Nat Chem Biol 4:564-573
416. Fossati E, Ekins A, Narcross L, Zhu Y, Falgueyret J-P, Beaudoin GAW, Facchini PJ, Martin VJJ (2014) Reconstitution of a 10-gene pathway for synthesis of the plant alkaloid dihydrosanguinarine in Saccharomyces cerevisiae Nat Commun 5:3283 doi:10 1038/ncomms4283
417. Minami H, Kim J-S, Ikezawa N, Takemura T, Katayama T, Kumagai H, Sato F (2008) Microbial production of plant benzylisoquinoline alkaloids Proc Natl Acad Sci U S A 105:7393-7398
418. Reichenauer TG, Germida JJ (2008) Phytoremediation of organic contaminants in soil and groundwater ChemSusChem 1:708-717
419. Doty SL, Shang TQ, Wilson AM, Tangen J, Westergreen AD, Newman LA, Strand SE, Gordon MP (2000) Enhanced metabolism of halogenated hydrocarbons in transgenic plants containing mammalian cytochrome P450 2E1 Proc Natl Acad Sci U S A 97:6287-629
420. Doty SL, James CA, Moore AL, Vajzovic A, Singleton GL, Ma C, Khan Z, Xin G, Kang JW, Park JY, Meilan R, Strauss SH, Wilkerson J, Farin F, Strand SE (2007) Enhanced phytoremediation of volatile environmental pollutants with transgenic trees Proc Natl Acad Sci U S A 104:16816-16821
421. Kawahigashi H, Hirose S, Ohkawa H, Ohkawa Y (2003) Transgenic rice plants expressing human CYP1A1 exude herbicide metabolites from their roots Plant Sci 165:373-381
422. Kawahigashi H, Hirose S, Ohkawa H, Ohkawa Y (2006) Phytoremediation of the herbicides atrazine and metolachlor by transgenic rice plants expressing human CYP1A1, CYP2B6, and CYP2C19 J Agric Food Chem 54:2985-2991
423. Kawahigashi H, Hirose S, Ohkawa H, Ohkawa Y (2005) Transgenic rice plants expressing human CYP1A1 remediate the triazine herbicides atrazine and simazine J Agric Food Chem 53:8557-8564
424. Jackson RG, Rylott EL, Fournier D, Hawari J, Bruce NC (2007) Exploring the biochemical properties and remediation applications of the unusual explosivedegrading P450 system XplA/B Proc Natl Acad Sci U S A 104:16822-16827
425. Gavilano LB, Coleman NP, Burnley L-E, Bowman ML, Kalengamaliro NE, Hayes A, Bush L, Siminszky B (2006) Genetic engineering of Nicotiana tabacum for reduced nornicotine content J Agric Food Chem 54:9071-9078
426. Lewis RS, Bowen SW, Keogh MR, Dewey RE (2010) Three nicotine demethylase genes mediate nornicotine biosynthesis in Nicotiana tabacum L: functional characterization of the CYP82E10 gene Phytochemistry 71:1988-1998
427. Itkin M, Heinig U, Tzfadia O, Bhide AJ, Shinde B, Cardenas PD, Bocobza SE, Unger T, Malitsky S, Finkers R, Tikunov Y, Bovy A, Chikate Y, Singh P, Rogachev I, Beekwilder J, Giri AP, Aharoni A (2013) Biosynthesis of antinutritional alkaloids in solanaceous crops is mediated by clustered genes Science 341:175-179
428. Tanaka Y, Brugliera F (2013) Flower colour and cytochromes P450 Philos Trans R Soc Lond B Biol Sci 368
429. Holton TA (1996) Plant transgenosis with flavanoid pathway enzyme gene in genetic engineering of altered flower color WO9636716A1, International Flower Developments Pty Ltd, Australia
430. Brugliera F, Tanaka Y, Mason J (2004) Flavonoid 3ʹ,5ʹ-hydroxylase genes of flowering plants and their use in manipulation of flower color WO2004020637A1, International Flower Developments Pty Ltd, Australia
431. Brugliera F (2009) Nucleotide sequences of flavonoid 3ʹ,5ʹ-hydroxylase and dihydroflavonol-4-reductase encoding gene and genetically modified plants with altered inflorescence WO2009062259A1, International Flower Developments Pty Ltd, Australia
432. Brugliera F (2010) Methods for engineering carnations with altered inflorescence color by expressing Viola and Salvia flavonoid 3ʹ,5ʹ-hydroxylase gene and Petunia dihydroflavonol-4-reductase gene WO2010069004A1, International Flower Developments Pty Ltd, Australia
433. Katsumoto Y, Fukuchi-Mizutani M, Fukui Y, Brugliera F, Holton TA, Karan M, Nakamura N, Yonekura- Sakakibara K, Togami J, Pigeaire A, Tao G-Q, Nehra NS, Lu C-Y, Dyson BK, Tsuda S, Ashikari T, Kusumi T, Mason JG, Tanaka Y (2007) Engineering of the rose flavonoid biosynthetic pathway successfully generated blue-hued flowers accumulating delphinidin Plant Cell Physiol 48:1589-1600
434. Straathof AJ, Panke S, Schmid A (2002) The production of fine chemicals by biotransformations Curr Opin Biotechnol 13:548-556
435. Julsing MK, Cornelissen S, Buhler B, Schmid A (2008) Heme-iron oxygenases: powerful industrial biocatalysts? Curr Opin Chem Biol 12:177-186
436. Westfall PJ, Pitera DJ, Lenihan JR, Eng D, Woolard FX, Regentin R, Horning T, Tsuruta H, Melis DJ, Owens A, Fickes S, Diola D, Benjamin KR, Keasling JD, Leavell MD, McPhee DJ, Renninger NS, Newman JD, Paddon CJ (2012) Production of amorphadiene in yeast, and its conversion to dihydroartemisinic acid, precursor to the antimalarial agent artemisinin Proc Natl Acad Sci U S A 109:E111-118
437. Guidelines for the treatment of malaria (2010) World Health Organization, Geneva, Switzerland
438. Guidance for industry-safety testing of drug metabolites (2008) UCM079266, US Department of health and human services, Silver Spring, Maryland, USA
439. Smith DA, Obach RS (2009) Metabolites in safety testing (MIST): considerations of mechanisms of toxicity with dose, abundance, and duration of treatment Chem Res Toxicol 22:267-279
440. Guideline on the investigation of drug interactions (2012) CPMP/EWP/560/95/Rev 1, European medicines agency, London, UK
441. 2007-2011 Flavor & fragrance industry leaders (2012) Leffingwell & Associates http://www leffingwell com/top_10 htm; 2014/03/20
442. Bommarius AS, Blum JK, Abrahamson MJ (2011) Status of protein engineering for biocatalysts: how to design an industrially useful biocatalyst Curr Opin Chem Biol 15:194-200